• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症中定时 25 英尺步行表现的定量综合。

Quantitative Synthesis of Timed 25-Foot Walk Performance in Multiple Sclerosis.

机构信息

School of Health Professions, University of Alabama at Birmingham, Birmingham, Alabama.

School of Health Professions, University of Alabama at Birmingham, Birmingham, Alabama.

出版信息

Arch Phys Med Rehabil. 2020 Mar;101(3):524-534. doi: 10.1016/j.apmr.2019.08.488. Epub 2019 Oct 24.

DOI:10.1016/j.apmr.2019.08.488
PMID:31669296
Abstract

OBJECTIVE

To provide a meta-analysis of articles that have included the timed 25-foot walk (T25FW) in persons with multiple sclerosis (MS), quantify differences in T25FW scores between those with MS and controls without MS, and quantify differences between categories of disability status and clinical disease courses within MS.

DATA SOURCES

The literature search was conducted using 4 databases (Google Scholar, PubMed, Cumulative Index to Nursing and Allied Health, EBSCO Host). We searched reference lists of published articles to identify additional articles.

STUDY SELECTION

A systematic literature search identified articles reporting average T25FW performance in seconds between those with MS and controls without MS, between those with MS who had mild and moderate and/or severe disability status, and between relapsing-remitting and progressive clinical courses of MS.

DATA EXTRACTION

Information was extracted and categorized based on reported data: comparisons of controls without MS and MS, comparisons of mild and moderate and/or severe MS based on study-defined Expanded Disability Status Scale groups, and comparisons of relapsing-remitting and progressive MS clinical courses.

DATA SYNTHESIS

We performed a random effects meta-analysis to quantify differences between groups as estimated by effect sizes (ESs). We expressed the differences in Cohen d as well as the original units of the T25FW (ie, seconds).

CONCLUSIONS

There was a large difference in T25FW performance in MS compared with controls without MS (ES=-0.93, mean difference=2.4s, P<.01). Persons with moderate and/or severe disability walked substantially slower compared with mild disability (ES=-1.02, mean difference=5.4s, P<.01), and persons with progressive courses of MS walked substantially slower than relapsing-remitting MS (ES=-1.4, mean difference=13.4s, P<.01).

摘要

目的

对纳入多发性硬化症(MS)患者定时 25 英尺步行(T25FW)的文献进行荟萃分析,量化 MS 患者与无 MS 对照者之间 T25FW 评分的差异,并量化 MS 残疾状况和临床病程类别之间的差异。

数据来源

使用 4 个数据库(Google Scholar、PubMed、护理与联合健康累积索引、EBSCO 主机)进行文献检索。我们搜索了已发表文章的参考文献列表,以确定其他文章。

研究选择

系统文献检索确定了报告 MS 患者与无 MS 对照者之间 T25FW 平均表现(以秒为单位)、MS 患者中轻度和中度/或重度残疾状态以及复发缓解型和进行性 MS 临床病程之间的文章。

数据提取

根据报告的数据提取和分类信息:无 MS 和 MS 对照者的比较、根据研究定义的扩展残疾状况量表组对轻度和中度/或重度 MS 的比较、以及复发缓解型和进行性 MS 临床病程的比较。

数据分析

我们进行了随机效应荟萃分析,以通过效应大小(ES)量化组间差异。我们用 Cohen d 表示差异,并用 T25FW 的原始单位(即秒)表示差异。

结论

MS 患者与无 MS 对照者相比,T25FW 表现差异较大(ES=-0.93,平均差异=2.4s,P<.01)。中度/或重度残疾患者的步行速度明显慢于轻度残疾患者(ES=-1.02,平均差异=5.4s,P<.01),进行性 MS 患者的步行速度明显慢于复发缓解型 MS(ES=-1.4,平均差异=13.4s,P<.01)。

相似文献

1
Quantitative Synthesis of Timed 25-Foot Walk Performance in Multiple Sclerosis.多发性硬化症中定时 25 英尺步行表现的定量综合。
Arch Phys Med Rehabil. 2020 Mar;101(3):524-534. doi: 10.1016/j.apmr.2019.08.488. Epub 2019 Oct 24.
2
Walking endurance in multiple sclerosis: Meta-analysis of six-minute walk test performance.多发性硬化症患者的步行耐力:6 分钟步行试验表现的荟萃分析。
Gait Posture. 2019 Sep;73:147-153. doi: 10.1016/j.gaitpost.2019.07.125. Epub 2019 Jul 10.
3
Does disability level impact the relationship of muscle strength to walking performance in people with multiple sclerosis? a cross-sectional analysis.残疾程度是否会影响多发性硬化症患者肌肉力量与行走能力之间的关系?一项横断面分析。
Mult Scler Relat Disord. 2020 Jul;42:102052. doi: 10.1016/j.msard.2020.102052. Epub 2020 Mar 13.
4
Comparison of the timed 25-foot and the 100-meter walk as performance measures in multiple sclerosis.比较多发性硬化症中定时 25 英尺和 100 米步行的表现测量。
Neurorehabil Neural Repair. 2011 Sep;25(7):672-9. doi: 10.1177/1545968310397204. Epub 2011 Mar 24.
5
Potential of Timed 25-Foot Walk Values in Predicting Maximum Walking Distance in Persons with Multiple Sclerosis.定时25英尺步行值预测多发性硬化症患者最大步行距离的潜力
Int J MS Care. 2020 Sep-Oct;22(5):215-218. doi: 10.7224/1537-2073.2019-052. Epub 2020 Jan 13.
6
A 3meter Timed Tandem Walk is an early marker of motor and cerebellar impairment in fully ambulatory MS patients.3米定时串联步行试验是完全可独立行走的多发性硬化症患者运动及小脑功能障碍的早期指标。
J Neurol Sci. 2014 Nov 15;346(1-2):99-106. doi: 10.1016/j.jns.2014.08.001. Epub 2014 Aug 10.
7
Natalizumab improves ambulation in relapsing-remitting multiple sclerosis: results from the prospective TIMER study and a retrospective analysis of AFFIRM.那他珠单抗可改善复发缓解型多发性硬化症患者的行走能力:前瞻性TIMER研究及AFFIRM回顾性分析结果
Eur J Neurol. 2015 Mar;22(3):570-7. doi: 10.1111/ene.12618. Epub 2014 Dec 15.
8
The six spot step test: a new measurement for walking ability in multiple sclerosis.六点步态测试:一种用于评估多发性硬化症患者步行能力的新测量方法。
Mult Scler. 2006 Aug;12(4):495-500. doi: 10.1191/1352458506ms1293oa.
9
The effect of exercise training in adults with multiple sclerosis with severe mobility disability: A systematic review and future research directions.运动训练对重度行动不便的成年多发性硬化症患者的影响:一项系统综述及未来研究方向
Mult Scler Relat Disord. 2017 Aug;16:31-39. doi: 10.1016/j.msard.2017.06.003. Epub 2017 Jun 12.
10
A corrected version of the Timed-25 Foot Walk Test with a dynamic start to capture the maximum ambulation speed in multiple sclerosis patients.改良的 25 英尺定时步行测试(Timed-25 Foot Walk Test),采用动态起始以捕捉多发性硬化症患者的最大步行速度。
NeuroRehabilitation. 2012;30(4):261-6. doi: 10.3233/NRE-2012-0754.

引用本文的文献

1
Assessing the role of volumetric brain information in multiple sclerosis progression.评估脑容量信息在多发性硬化症进展中的作用。
Comput Struct Biotechnol J. 2025 May 12;27:2014-2033. doi: 10.1016/j.csbj.2025.05.003. eCollection 2025.
2
Intrathecal methotrexate in progressive multiple sclerosis: a phase 1 open-label study with long-term follow-up.鞘内注射甲氨蝶呤治疗进展性多发性硬化症:一项长期随访的1期开放标签研究。
J Neurol. 2025 May 4;272(5):374. doi: 10.1007/s00415-025-13114-z.
3
Association between the Hopkins Falls grading scale and motor function tests in patients with multiple sclerosis.
霍普金斯瀑布分级量表与多发性硬化症患者运动功能测试之间的关联。
J Family Med Prim Care. 2024 May;13(5):2099-2103. doi: 10.4103/jfmpc.jfmpc_1660_23. Epub 2024 May 24.
4
Clinical outcome assessments of disease burden and progression in late-onset GM2 gangliosidoses.迟发性 GM2 神经节苷脂贮积症疾病负担和进展的临床结局评估。
Mol Genet Metab. 2024 Jul;142(3):108512. doi: 10.1016/j.ymgme.2024.108512. Epub 2024 Jun 6.
5
Effects of vibration training on motor and non-motor symptoms for patients with multiple sclerosis: A systematic review and meta-analysis.振动训练对多发性硬化症患者运动和非运动症状的影响:一项系统评价和荟萃分析。
Front Aging Neurosci. 2022 Aug 5;14:960328. doi: 10.3389/fnagi.2022.960328. eCollection 2022.
6
Walking With Horizontal Head Turns Is Impaired in Persons With Early-Stage Multiple Sclerosis Showing Normal Locomotion.在早期多发性硬化症患者中,尽管其行走功能正常,但在水平转头行走时会受到损害。
Front Neurol. 2022 Jan 28;12:821640. doi: 10.3389/fneur.2021.821640. eCollection 2021.
7
Measuring Treatment Response in Progressive Multiple Sclerosis-Considerations for Adapting to an Era of Multiple Treatment Options.评估进展性多发性硬化症的治疗应答——考虑适应多种治疗选择的时代。
Biomolecules. 2021 Sep 10;11(9):1342. doi: 10.3390/biom11091342.
8
Outcome measures assisting treatment optimization in multiple sclerosis.用于协助多发性硬化症治疗优化的结局指标。
J Neurol. 2022 Mar;269(3):1282-1297. doi: 10.1007/s00415-021-10674-8. Epub 2021 Aug 2.
9
The timed 25-foot walk in a large cohort of multiple sclerosis patients.在一大群多发性硬化症患者中进行定时 25 英尺行走测试。
Mult Scler. 2022 Feb;28(2):289-299. doi: 10.1177/13524585211017013. Epub 2021 Jun 8.
10
Cognitive Processing Speed Impairment Does Not Influence the Construct Validity of Six-Spot Step Test Performance in People With Multiple Sclerosis.认知加工速度损伤不会影响多发性硬化症患者六步台阶测试表现的结构效度。
Phys Ther. 2021 Feb 4;101(2). doi: 10.1093/ptj/pzaa227.